[
  {
    "ts": null,
    "headline": "Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Is Strong Tailwind",
    "summary": "Biotech stock Kiniksa soared after first-quarter results on April 29. Shares are near a buy point of 28.15.",
    "url": "https://finnhub.io/api/news?id=8fa832ed894c14a3f300177cc8d1e89d67760ca4540c714810fda639571ec631",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751391435,
      "headline": "Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Is Strong Tailwind",
      "id": 135698125,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Biotech stock Kiniksa soared after first-quarter results on April 29. Shares are near a buy point of 28.15.",
      "url": "https://finnhub.io/api/news?id=8fa832ed894c14a3f300177cc8d1e89d67760ca4540c714810fda639571ec631"
    }
  },
  {
    "ts": null,
    "headline": "Anne Wojcicki's nonprofit gets court approval to buy 23andMe for $305 million",
    "summary": "Anne Wojcicki's bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight.  The transaction — which arrives more than three months after 23andMe filed for Chapter 11 bankruptcy — is set to officially close in the coming weeks.  “I am thrilled that TTAM will be able to build on the mission of 23andMe to help people access, understand and benefit from the human genome,\" Wojcicki said in a statement Monday — later adding that, \"the future of health care belongs to all of us.”",
    "url": "https://finnhub.io/api/news?id=1720ff3c0a5ecb2bc736c4bfac70c47ce2dc3cfb0427f69e48937c1a9679c0fb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751381141,
      "headline": "Anne Wojcicki's nonprofit gets court approval to buy 23andMe for $305 million",
      "id": 135692985,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Anne Wojcicki's bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight.  The transaction — which arrives more than three months after 23andMe filed for Chapter 11 bankruptcy — is set to officially close in the coming weeks.  “I am thrilled that TTAM will be able to build on the mission of 23andMe to help people access, understand and benefit from the human genome,\" Wojcicki said in a statement Monday — later adding that, \"the future of health care belongs to all of us.”",
      "url": "https://finnhub.io/api/news?id=1720ff3c0a5ecb2bc736c4bfac70c47ce2dc3cfb0427f69e48937c1a9679c0fb"
    }
  },
  {
    "ts": null,
    "headline": "Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Strong Tailwind",
    "summary": "Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Strong Tailwind",
    "url": "https://finnhub.io/api/news?id=abe1cc34809e0374b72c071c7855d3d512adfa14cf62b9cb906642bd0b97542c",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751377035,
      "headline": "Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Strong Tailwind",
      "id": 135818507,
      "image": "",
      "related": "REGN",
      "source": "DowJones",
      "summary": "Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Strong Tailwind",
      "url": "https://finnhub.io/api/news?id=abe1cc34809e0374b72c071c7855d3d512adfa14cf62b9cb906642bd0b97542c"
    }
  }
]